Basit öğe kaydını göster

dc.contributor.authorShehab, Abdulla
dc.contributor.authorElnour, Asim Ahmed
dc.contributor.authorAl Swaidi, Shirina
dc.contributor.authorBhagavathula, Akshaya Srikanth
dc.contributor.authorHamad, Farah
dc.contributor.authorShehab, Omar
dc.contributor.authorAbuMandil, Mahmoud
dc.contributor.authorAbasaeed, AboBakr
dc.contributor.authorDahab, Ahmed
dc.contributor.authorAl Kalbani, Naama
dc.contributor.authorAbdulla, Rouda
dc.contributor.authorAsim, Sahar
dc.contributor.authorErkekoglu, Pinar
dc.contributor.authorAl Nuaimi, Saif
dc.contributor.authorAl Suwaidi, Aaesha
dc.date.accessioned2019-12-16T10:09:48Z
dc.date.available2019-12-16T10:09:48Z
dc.date.issued2016
dc.identifier.issn1319-0164
dc.identifier.urihttps://doi.org/10.1016/j.jsps.2015.02.022
dc.identifier.urihttp://hdl.handle.net/11655/19974
dc.description.abstractObjective: There are limited number of studies describing the reasons and interventions of non-adherence to cardiovascular medications in United Arab Emirates (UAE). We aimed to implement and evaluate the behavioral and educational tools that indicate the reasons of non-adherence in patients with cardiovascular diseases and improve patient's adherence to their cardiovascular medications. Methods: In this prospective interventional study, we recruited patients (n=300) with cardiovascular diseases from three family medicine clinics in Al Ain, UAE in 2010. We assessed patients' responses to a validated brief medication questionnaire (BMQ). Results: At the end of the study, we observed a significant improvement in adherence. When we compared pre- and post-interventions, the mean (+/- standard deviation, SD) score for non-adherence to current regimen were 4.1 +/- 0.2 vs. 3.0 +/- 0.3 (p=0.034); indication of negative believes or motivational barriers scores was 1.8 +/- 0.4 vs. 0.9 +/- 0.1 (p=0.027); the indication of recall barrier scores was 1.6 +/- 0.1 vs. 0.8 +/- 0.1 (p=0.014); and the indication of access barrier scores was 1.6 +/- 0.2 vs. 0.7 +/- 0.2 (p=0.019). Mean blood pressure, fasting blood glucose, glycosylated hemoglobin, low density lipoprotein and postprandial blood glucose decreased significantly (p<0.01) post-intervention. Conclusion: We reported that implemented multifaceted tools targeting patients, provider and healthcare system have improved the adherence to cardiovascular medications. Our interventions managed to improve patients' clinical outcome via improving adherence to prescribed cardiovascular medications. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
dc.language.isoen
dc.publisherElsevier Science Bv
dc.relation.isversionof10.1016/j.jsps.2015.02.022
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPharmacology & Pharmacy
dc.titleEvaluation And Implementation Of Behavioral And Educational Tools That Improves The Patients' Intentional And Unintentional Non-Adherence To Cardiovascular Medications In Family Medicine Clinics
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalSaudi Pharmaceutical Journal
dc.contributor.departmentFarmasötik Toksikoloji
dc.identifier.volume24
dc.identifier.issue2
dc.identifier.startpage182
dc.identifier.endpage188
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster